CN101843694A - Chinese medicament for treating chronic hepatitis - Google Patents
Chinese medicament for treating chronic hepatitis Download PDFInfo
- Publication number
- CN101843694A CN101843694A CN200910093716A CN200910093716A CN101843694A CN 101843694 A CN101843694 A CN 101843694A CN 200910093716 A CN200910093716 A CN 200910093716A CN 200910093716 A CN200910093716 A CN 200910093716A CN 101843694 A CN101843694 A CN 101843694A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese
- chinese medicine
- chronic hepatitis
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 206010008909 Chronic Hepatitis Diseases 0.000 title claims abstract description 13
- 208000006454 hepatitis Diseases 0.000 title claims abstract description 13
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims description 17
- 239000002775 capsule Substances 0.000 claims description 16
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 10
- 241000180649 Panax notoginseng Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- 210000004185 liver Anatomy 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract description 2
- 208000010643 digestive system disease Diseases 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000306301 Caesalpinia sappan Species 0.000 abstract 1
- 235000015162 Caesalpinia sappan Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 230000002440 hepatic effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010019668 Hepatic fibrosis Diseases 0.000 description 3
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- AXONCVPTTFHNOI-UHFFFAOYSA-N kairine Chemical compound C1=CC(O)=C2N(C)CCCC2=C1 AXONCVPTTFHNOI-UHFFFAOYSA-N 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a Chinese medicament for treating chronic hepatitis, and belongs to the field of Chinese medicaments for treating digestive system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: spreading hedyotis herb, radix pseudo-ginseng, lucid ganoderma, green tangerine peel, Chinese angelica, root of rehmannia, sappan wood and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, and soothing liver and relieving pain, and has the advantages of obvious effect, exact medicinal effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment digestive system disease.
Background technology
The present field of Chinese medicines that is intended to treat chronic hepatitis, the deficiency of two aspects of existence: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that large quantities of chronic hepatitis patients are because of can not get the treatment of active drug, liver disease constantly develops, and clinical symptoms can not get alleviating, and the patient is seriously weak for a long time, dull pain in liver, liver function descend, hepatic fibrosis is serious etc., patient's life quality descends, and I and family members are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of chronic hepatitis, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of chronic hepatitis adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Hedyotidis Diffusae 4---15 parts of 30 portions of Radix Notoginseng 2---15 portions of Ganodermas 1.5---
Pericarpium Citri Reticulatae Viride 2---30 parts of 15 parts of Radix Angelicae Sinensis 4---30 parts of Radix Rehmanniae 4---
Lignum Sappan 2---15 parts
The Chinese medicine of this treatment chronic hepatitis is made by following method:
(1) by above-mentioned weight ratio, Herba Hedyotidis Diffusae, Pericarpium Citri Reticulatae Viride, Radix Angelicae Sinensis, the Radix Rehmanniae, Lignum Sappan are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.The chronic hepatitis obstinate, state of an illness delay 5 years, time more than 10 years even 20 years, immunity is seriously low.Ganoderma, Radix Rehmanniae benefiting QI and nourishing blood, tonification the five internal organs in the side, enhancing human body immunity power; Radix Angelicae Sinensis, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling; 5 with Herba Hedyotidis Diffusae heat-clearing and toxic substances removing, inducing diuresis and reducing edema; The soothing the liver dispelling the stagnated QI of Pericarpium Citri Reticulatae Viride rushes down pain relieving clearly; Lignum Sappan goes into Liver Channel, blood circulation promoting and blood stasis dispelling, inducing menstruation to relieve menalgia.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, the merit of Shugan Zhitong, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Herba Hedyotidis Diffusae 60 gram Radix Notoginseng 40 kairine sesames 30 grams
The Pericarpium Citri Reticulatae Viride 40 gram Radix Angelicae Sinensis 60 gram Radix Rehmanniae 60 grams
Lignum Sappan 40 grams
Weight in accordance with regulations, with conventional water extraction process Herba Hedyotidis Diffusae, Pericarpium Citri Reticulatae Viride, Radix Angelicae Sinensis, the Radix Rehmanniae, Lignum Sappan are extracted, make extractum fine powder 78 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 529 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Herba Hedyotidis Diffusae 160 gram Radix Notoginseng 90 kairine sesames 90 grams
The Pericarpium Citri Reticulatae Viride 100 gram Radix Angelicae Sinensis 160 gram Radix Rehmanniae 160 grams
Lignum Sappan 100 grams
By above-mentioned same method, make 1473 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Herba Hedyotidis Diffusae 300 gram Radix Notoginseng 150 kairine sesames 150 grams
The Pericarpium Citri Reticulatae Viride 150 gram Radix Angelicae Sinensis 300 gram Radix Rehmanniae 300 grams
Lignum Sappan 150 grams
By above-mentioned same method, make 2357 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
3 parts of 3 portions of Ganodermas of 5 portions of Radix Notoginseng of Herba Hedyotidis Diffusae
4 parts in 4 parts of Radix Rehmanniae of 3 parts of Radix Angelicae Sinensis of Pericarpium Citri Reticulatae Viride
3 parts of Lignum Sappans
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
10 parts of 10 portions of Ganodermas of 25 portions of Radix Notoginseng of Herba Hedyotidis Diffusae
20 parts in 20 parts of Radix Rehmanniae of 12 parts of Radix Angelicae Sinensis of Pericarpium Citri Reticulatae Viride
12 parts of Lignum Sappans
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science chronic hepatitis, through 13 routine clinical observations.Selecting the tcm diagnosis chronic hepatitis is standard: limb is soft weak, and is weak from head to foot; Poor appetite, abdominal distention, dyspepsia; Face is pitch-dark, hepatic face is arranged; Dull pain in liver; Hepatic fibrosis is serious; It is undesired that liver function transaminase continues, and other index such as plasma albumin, blood total bilirubin etc. are defective.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 8 examples, women's 5 examples do not have other serious disease, and the age is 52 years old-77 years old, 61.3 years old mean age.
Efficacy determination:
1, produce effects: weak alleviation, on one's body energetically; Poor appetite, abdominal distention, dull pain in liver are alleviated, and the hepatic region is comfortable; Hepatic face is taken on a new look to some extent, and it is pale that face becomes; The hepatic fibrosis inspection is alleviated obviously; Indexs such as liver function test transaminase, plasma albumin are obviously improved.
2, effective: weak solution, on one's body energetically, abdominal distention, poor appetite, hepatic face are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 5 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.13 philtrums of clinical experiment, produce effects 5 people, effective 7 people, invalid 1 people, total effective rate 92.3%.
Claims (1)
1. a Chinese medicine for the treatment of chronic hepatitis adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Hedyotidis Diffusae 4---15 parts of 30 portions of Radix Notoginseng 2---15 portions of Ganodermas 1.5---
Pericarpium Citri Reticulatae Viride 2---30 parts of 15 parts of Radix Angelicae Sinensis 4---30 parts of Radix Rehmanniae 4---
Lignum Sappan 2---15 parts
The Chinese medicine of this treatment chronic hepatitis is made by following method:
(1) by above-mentioned weight ratio, Herba Hedyotidis Diffusae, Pericarpium Citri Reticulatae Viride, Radix Angelicae Sinensis, the Radix Rehmanniae, Lignum Sappan are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910093716XA CN101843694B (en) | 2009-09-25 | 2009-09-25 | Traditional Chinese medicine for treating chronic hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910093716XA CN101843694B (en) | 2009-09-25 | 2009-09-25 | Traditional Chinese medicine for treating chronic hepatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101843694A true CN101843694A (en) | 2010-09-29 |
| CN101843694B CN101843694B (en) | 2012-04-04 |
Family
ID=42768630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910093716XA Expired - Fee Related CN101843694B (en) | 2009-09-25 | 2009-09-25 | Traditional Chinese medicine for treating chronic hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101843694B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101953924A (en) * | 2010-10-14 | 2011-01-26 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic hepatitis |
| CN101979006A (en) * | 2010-10-27 | 2011-02-23 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating chronic hepatitis |
| CN102091165A (en) * | 2010-11-25 | 2011-06-15 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic hepatitis |
| CN102114109A (en) * | 2010-12-13 | 2011-07-06 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic hepatitis |
| CN102172375A (en) * | 2010-12-20 | 2011-09-07 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic hepatitis |
| CN109091590A (en) * | 2018-10-11 | 2018-12-28 | 田国荣 | A kind of ginseng and astragalus hepar kang tablet and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1325102C (en) * | 2005-05-20 | 2007-07-11 | 李素梅 | Ready prepared Chinese medicine for treating diabetes |
| CN1947777A (en) * | 2006-06-18 | 2007-04-18 | 芮育健 | Method for treating diabets by Fuling, wolfberry fruit and radix scrophulariae with producing saliva and slaking thirst function |
-
2009
- 2009-09-25 CN CN200910093716XA patent/CN101843694B/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101953924A (en) * | 2010-10-14 | 2011-01-26 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic hepatitis |
| CN101979006A (en) * | 2010-10-27 | 2011-02-23 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating chronic hepatitis |
| CN102091165A (en) * | 2010-11-25 | 2011-06-15 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic hepatitis |
| CN102114109A (en) * | 2010-12-13 | 2011-07-06 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic hepatitis |
| CN102172375A (en) * | 2010-12-20 | 2011-09-07 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic hepatitis |
| CN109091590A (en) * | 2018-10-11 | 2018-12-28 | 田国荣 | A kind of ginseng and astragalus hepar kang tablet and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101843694B (en) | 2012-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843787B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843694B (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101843804A (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843789A (en) | Chinese medicament for treating gout | |
| CN101843704B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843740B (en) | Chinese medicament for treating climacteric syndromes | |
| CN101850046B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843707B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843726B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101884747B (en) | Traditional Chinese medicine for treating chronic nephritis | |
| CN101850078B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843693A (en) | Chinese medicament for treating diabetic nephropathy | |
| CN101843734B (en) | Chinese medicament for treating abnormal menstruation | |
| CN101843825B (en) | Chinese medicament for treating climacteric syndromes | |
| CN101843709A (en) | Chinese medicament for treating abnormal menstruation | |
| CN101843817B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843745B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101874870B (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101843756B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843750B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843818B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843816B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843698A (en) | Chinese medicament for treating cervical spondylosis | |
| CN101879246A (en) | Traditional Chinese medicine for treating lupus erythematosus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120404 Termination date: 20120925 |